Pacific Meso Center Scientific Advisor Dr. Robert Cameron
| Dr. Robert Cameron |
The Pacific Meso Center is proud to have Dr. Robert Cameron as its Scientific Advisor. Dr. Cameron is one of the leading experts on the treatment of pleural mesothelioma, a rare cancer of the linings of the lungs caused by asbestos.
Through its association with Dr. Cameron, PMC is an authoritative resource from which mesothelioma patients can obtain information on the latest treatment options as well as access to other patients, Dr. Cameron's Nurse Practitioner Anne Rorie and Dr. Cameron himself, to help them make informed treatment decisions. PMC also supports the research efforts of Dr. Cameron which may someday lead to a cure for mesothelioma.
Dr. Robert Cameron’s Background and Qualifications
Dr. Robert Cameron is a cardiothoracic surgeon and surgical oncologist who specializes in the treatment of malignant pleural mesothelioma. Dr. Cameron is the director of the mesothelioma program at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA) and the chief of thoracic surgery at the West Los Angeles Veterans’ Administration Medical Center.
Dr. Cameron is board certified in general surgery and cardiothoracic surgery. He attended medical school at the University of Michigan and UCLA, where he obtained his medical degree and was elected to early membership in the Alpha Omega Alpha Honor Society after his second year at the University of Michigan (top 4% of students). He completed three years of training as a clinical associate in surgical oncology at the National Cancer Institute of the National Institutes of Health in Bethesda, Maryland, a five-year residency in general surgery at UCLA, and a two-year fellowship in cardiothoracic surgery at Cornell-New York Hospital and Memorial Sloan-Kettering Cancer Center in New York City.
Dr. Cameron is a fellow in the American College of Surgeons and a member of the Society of Surgical Oncology, the Society of Thoracic Surgeons, the Western Thoracic Surgical Association, the American Society of Clinical Oncology, the International Association for the Study of Lung Cancer, the Pacific Coast Surgical Association, the International Society for Biologic Therapy of Cancer, the American Association for Cancer Research and the International College of Surgeons.
Dr Cameron has authored or co-authored more than 35 papers regarding oncology, thoracic surgery, and other topics subject to peer review in medical journals, as well as more than 38 book chapters. He has edited two textbooks, one on laboratory research techniques and one, Practical Oncology, on the treatment of cancer. He has given numerous invited lectures. He has reviewed articles submitted by others for Annals of Thoracic Surgery, Cancer Research, the Annals of Surgical Oncology, Lung Cancer, the Journal of Immunology, the Journal of the National Cancer Institute, the Annals of Surgery, the Journal of Immunotherapy, and as well as other publications.
Dr. Cameron is a co-founder and former director of the Mesothelioma Applied Research Foundation, the first medical research foundation dedicated to sponsoring research into advancements in the diagnosis and treatment of mesothelioma.
Dr. Cameron has been treating mesothelioma patients for over 20 years. He is the innovator of the lung-sparing Pleurectomy/Decortication surgical procedure for mesothelioma and has performed the procedure on hundreds of patients to date.
Dr. Robert Cameron’s Curriculum Vitae
| Full Name: | Robert Brian Cameron, M.D. | |
| Academic Title: | Associate Professor Cardiothoracic Surgery and Surgical Oncology Chief, Thoracic Surgery Director, Thoracic Oncology Department of Surgery UCLA School of Medicine Chief, Thoracic Surgery West Los Angeles Veterans Administration Hospital |
|
Work Address: |
Department of Surgery UCLA School of Medicine Center for the Health Sciences, Room 64-128 10833 Le Conte Avenue Box 957313 Los Angeles, California 90095-1741 email: rcameron@mednet.ucla.edu |
|
Telephone: |
(310) 794-7333 (office) (310) 794-7335 (fax) |
|
| ACADEMIC APPOINTMENTS | ||
Associate Professor of Clinical Surgery |
||
Institution: |
University of California, Los Angeles Los Angeles, California July, 2001-present Chief, Division of Thoracic Surgery Surgical Director, Thoracic Oncology Program Surgical Director, Lung Volume Reduction Surgery Program UCLA Medical Center West Los Angeles, Veterans Administration Los Angeles, California July, 2001-present Chief, Division of Thoracic Surgery Wadsworth VA Hospital |
|
| Associate Professor of Surgery | ||
Institution: |
University of California, Los Angeles Los Angeles, California March, 1997-July, 2001 Chief, Section of Thoracic Surgery Surgical Director, Thoracic Oncology Program UCLA Medical Center West Los Angeles, Veterans Administration Los Angeles, California February, 1998-July, 2001 Chief, Division of Thoracic Surgery Wadsworth VA Hospital |
|
| Associate Professor of Surgery | ||
Institution:
Location: Dates: Title: Hospitals: |
University of California, San Francisco San Francisco, California September, 1994-February, 1997 Chief, Section of General Thoracic Surgery Moffitt-Long Hospital UCSF-Mt Zion Medical Center San Francisco Veteran’s Administration Medical Center San Francisco General Hospital Kaiser Permanente Hospital, San Francisco |
|
| EDUCATION | ||
| Medical Education | ||
Institution: |
University of Michigan Ann Arbor, Michigan August, 1980-August, 1982 University of California, Los Angeles Los Angeles, California August, 1982-June, 1984 M.D. |
|
| Undergraduate Education | ||
Institution: |
Stanford University Stanford, California September, 1976-June, 1980 Bachelor of Arts and Science (B.A.S.) in medieval studies and biology |
|
| TRAINING | ||
| Cardiothoracic Surgery | ||
Position: |
Fellow in Cardiothoracic Surgery New York Hospital-Cornell Medical Center/Memorial Sloan-Kettering Cancer New York, New York July, 1992-June, 1994 |
|
| General Surgery | ||
Position: |
Senior and Chief Resident University of California, Los Angeles Los Angeles, California July, 1989-June, 1992 |
|
| Surgical Oncology | ||
Position: |
Clinical Associate in Surgical Oncology Surgery Branch, National Cancer Institute, National Institutes of Health Bethesda, Maryland July, 1986-June, 1989 |
|
| General Surgery | ||
Position: |
Intern and Resident University of California, Los Angeles Los Angeles, California July, 1984-June, 1986 |
|
HONORS
| Phi Beta Kappa Membership; Stanford University (as junior student): June, 1979 |
Departmental Distinction; Department of Biology, Stanford University: June, 1980 Alpha Omega Alpha Membership; University of Michigan Medical School (as junior student): December, 1982 |
Outstanding Faculty Educator, Thoracic Surgery, UCLA Dept. of Surgery, June, 2001
Board Certification
General Surgery: May 5, 1993 (valid until July 1, 2003)
General Surgery recertification: October 18, 2002 (valid until July 1, 2013)
Cardiothoracic Surgery (certificate #5615): June 2, 1995 (valid until December 31, 2005)
Medical Licensure
California: G56430 (active)
Maryland: (inactive)
Virginia: (inactive)
New York: (inactive)
Society Memberships
Phi Beta Kappa Honor Society: since 1979
American Medical Association: since 1980
Alpha Omega Alpha Honorary Society: since 1982
American College of Surgeons Candidate Member: 1986-1994
American College of Surgeons Associate Member: 1994-1997
American Association of Immunologists: 1986-1992
New York Academy of Sciences: since 1987
American Association for the Advancement of Science: since 1987
American College of Cardiology: 1992-1996
New York Society for Thoracic Surgery: since 1993
Longmire Surgical Society: since 1993
New York Hospital-Cornell Cardiothoracic Surgical Society: since 1994
Society of Surgical Oncology: since 1995
San Francisco Surgical Society: since 1996
American College of Surgeons Fellow: since 1997
Society of Thoracic Surgeons: since 1997
American Association for Cancer Research: since 1998
American Society for Clinical Oncology: since 2000
International Association for the Study of Lung Cancer: since 2004
International Association for the Study of Lung Cancer: since 2004
Group Memberships
UCSF-Mt Zion Cancer Center Thoracic Tumor Board (Chairman): 1994-1997
UCSF-Mt Zion Cancer Center: 1995-1997
Cancer and Leukemia Group B (Investigator): 1995-1997
UCSF Thoracic Oncology Research Group: 1995-1997
UCLA-Jonsson Comprehensive Cancer Center Thoracic Tumor Board (Chairman): 1997-present
Southwest Oncology Group (Investigator): 1997-present
American College of Surgeons Oncology Group (UCLA Principle Investigator): 1999-present
Committees
Local/Regional
Preferred Oncology Network of California Lung Cancer Committee (Chairman): 1994-1995
UCSF Cancer Center Protocol Review Committee: 1995-1997
UCSF Cancer Center Steering Committee: 1995-1997
UCSF-Mt Zion Quality Improvement Council: 1995-1997
UCSF-Mt Zion Surgery Committee: 1996-1997
UCLA-Jonsson Comprehensive Cancer Center Qualtiy Assurance Committee: 1997-present
UCLA-Jonsson Comprehensive Cancer Center Committee: 1997-present
UCLA Cancer Committee: 1997-present
UCLA Pain Management Task Force: 2000-present
UCLA ad hoc Peer Review Committee: 2005-present
National/International
CALGB Surgery Committee: 1995-1997
CALGB Thoracic Surgery Subcommittee: 1995-1997
CALGB Respiratory Committee: 1995-1997
SWOG Lung Committee: 1997-present
SWOG Thoracic Surgery Subcommittee: 1998-present
ACSOG Thoracic Committee: 1999-present
SSO Clinical Affairs Committee: 2005-present
Reviewer of Scientific Articles
Cancer ResearchJournal of Immunology
Journal of the National Cancer Institute
Annals of Surgery
Journal of Immunotherapy
Surgical Endoscopy
Lung Cancer
World Journal of Surgery
Annals of Thoracic Surgery
Consultant
Hemacell, Inc, San Francisco, California: 1993-present
Preferred Health Systems, LLC, Bethesda, Maryland: 1996
Axiom Medical, Rancho Dominguez, California: 2000-present
Pacific Heart, Lung, & Blood Institute: 2002-present
Patents
Bioengineered human blood cells: U.S. patent 5,599,705: issued: February 4, 1997; Australian patent issued
Genetic modification of human blood cells: U.S. patent 5,811,301; issued: September, 9, 1998
Research Topics
1. Cell inactivation by heat (hyperthermia): Stanford University School of Medicine (Drs. George M. Hahn and Gloria Li); 1975-1976.
2. Inhibition of interleukin-2 production by melanoma tumor cell extracts: UCLA School of Medicine (Dr. Donald Morton); 1984.
3. Synergistic antitumor effects of interleukin-2 and interferon-a: National Cancer Institute, National Institutes of Health (Dr. Steven A. Rosenberg); 1987.
4. Antitumor effects of allogeneic bone marrow transplantation: National Cancer Institute, National Institutes of Health (Drs. Steven A. Rosenberg and David Sachs); 1987.
5. Normal and antitumor effects of granulocyte-macrophage colony stimulating factor (GM-CSF): National Cancer Institute, National Institutes of Health (Dr. Steven A. Rosenberg); 1988.
6. Methods of mass production of human lymphocytes for use in human immunotherapy trials: National Cancer Institute, National Institutes of Health (Dr. Steven A. Rosenberg); 1988.
7. Normal and antitumor effects of macrophage colony stimulating factor (M-CSF): National Cancer Institute, National Institutes of Health (Dr. Steven A. Rosenberg); 1989.
8. Synergistic antitumor effects of interleukin-2, tumor-infiltrating lymphocytes, and local irradiation: National Cancer Institute, National Institutes of Health (Dr. Steven A. Rosenberg); 1989.
9. Specific cellular antigens in human lung cancer: UCSF School of Medicine and UCLA School of Medicine 1994-present.
10. Role of interleukin-4 in lung cancer and mesothelioma: UCSF School of Medicine and UCLA School of Medicine, 1995-present.
11. Role of intraoperative radiation in human mesothelioma: UCSF School of Medicine and UCSF-Mt. Zion Cancer Center; 1994-1997.
12. Dendritic cell-derived vaccines in human lung cancer: UCSF School of Medicine and UCLA School of Medicine; 1996-present.
13. Photodynamic Therapy in lung cancer, mesothelioma and esophageal disease: UCLA School of Medicine and Jonsson Comprehensive Cancer Center; 1997-present.
14. Respiratory monitoring in thoracic surgical patients: UCLA School of Medicine and Jonsson Comprehensive Cancer Center, 2001-present
Invited Lectures
1. Cameron RB. Bleomycin toxicity and bleomycin lung. Surgery Branch Grant Rounds, National Cancer Institute, National Institutes of Health, Bethesda, MD: November 11, 1983.
2. Cameron RB. Video-assisted thoracic surgery. Association of Operating Room Nurses (AORN), San Francisco/Marin County Chapter Educational Program, Shriner’s Hospital for Crippled Children, San Francisco, California: November 9, 1994.
3. Cameron RB. Neoadjuvant therapy followed by resection for stage IIIA lung cancer. 15th Annual Current Approaches to Radiation Oncology, Biology, and Physics, San Francisco, California: March 13, 1995
4. Cameron RB. New methods in the treatment of lung cancer. Grand Rounds, Brookside Hospital, San Pablo, California: April 4, 1995.
5. Bueff HU and Cameron RB. Thoracoscopy with thoracic disk excision. Debating Complex Issues in Spine Surgery, American Academy of Orthopaedic Surgeons Annual Meeting, San Francisco, California: April 7, 1995.
6. Cameron RB. Surgical treatment of lung cancer. UCSF Postgraduate Course in General Surgery, San Francisco, California: April 21, 1995.
7. Cameron RB. Iatrogenic esophageal trauma. American College of Surgeons Northern California Chapter Meeting, San Francisco, California: May 13, 1995.
8. Cameron RB and Urba W. Immunotherapy of cancer III: Discussion. 9th International Immunology Congress, San Francisco, California: July 25, 1995.
9. Cameron RB. Lung cancer. Cancer Registry Training Program, UCSF Department of Epidemiology and Biostatistics, San Francisco, California: August 10, 1995
10. Cameron RB. Surgical treatment of locally-advanced non-small cell lung cancer. Grand Rounds, Mt Diablo Medical Center, Concord, California: September 15, 1995.
11. Cameron RB. Lung Reduction Surgery in COPD. 14th Annual Recent Advances in Pulmonary and Critical Care Medicine, San Francisco, California: October 19, 1995.
12. Cameron RB. Thorascopic approaches to the thoracic spine. Minimally Invasive Anterior Approaches to Thoracic and Lumbar Spine Surgery, San Francisco, California: November 10, 1995.
13. Cameron RB. Lung cancer. Cancer Registry Training Program, UCSF Department of Epidemiology and Biostatistics, San Francisco, California: February 7, 1996
14. Cameron RB. Lung Reduction Surgery in COPD. Medical Grand Rounds. Kaiser Permanente Medical Center, Oakland, California: April 9, 1996.
15. Cameron RB. T cell recognition of non-small cell lung cancer. General Thoracic Biology Club; 76th Annual Meeting of the American Association for Thoracic Surgery, San Diego, California: April 28, 1996.
16. Cameron RB. What the thoracic surgeon needs from the diagnostic pathologist. 12th Annual Current Issues in Anatomic Pathology: 1996, San Francisco, California: May 24, 1996.
17. Cameron RB. Lung cancer. Cancer Registry Training Program, UCSF Department of Epidemiology and Biostatistics, San Francisco, California: August 7, 1996.
18. Cameron RB. Neoadjuvant chemotherapy in the treatment of locally-advanced non-small cell lung cancer. Thoracic Surgery Grand Rounds, UCLA Medical Center, Los Angeles, California: September 10, 1996.
19. Cameron RB. Lung reduction surgery in COPD. 15th Annual Recent Advances in Pulmonary and Critical Care Medicine, San Francisco, California: October 18, 1996.
20. Cameron RB. The surgeon’s approach to lung cancer. Quarterly Oncology Conference, Mercy Medical Center, Redding, California: November 16, 1996.
21. Cameron RB. Lung cancer. Medical Education Speakers Network, Northridge Hospital Medical Center, Northridge California: November 4, 1997.
22. Cameron, RB. Surgical Approaches to Lung Cancer. Los Angeles Radiologic Society/Southern California Radiation Oncology Society Annual Meeting, Universal City, California: January 23, 1999.
23. Beseth B, Bedford R, Isacoff W, Holmes EC, and Cameron RB. Endoscopic ultrasound does not accurately assess pathology stage of esophageal cancer following neoadjuvant chemoradiotherapy. American College of Surgeons Southern California Chapter Meeting, Huntington Beach, California, January 21, 2000.
24. Beseth B and Cameron, RB. Closure of parenchymal air leaks and buttressing of bronchial closures in an ex vivo swine model. American College of Surgeons Southern California Chapter Meeting, Huntington Beach, California, January 22, 2000.
25. Beseth B, Cameron RB, Leland P, You L, Varricchio F, Kreitman R, Maki RA, Pastan I, Jablons DM, Husain SR, Puri R. Cytotoxin directed to Interleukin-4 receptors for therapy of human malignant pleural mesothelioma xenographs. Society of Thoracic Surgeons 39th Annual Meeting, San Diego, California, January 31, 2003.
26. Cárdenas, AF, Pon, RK, and Cameron, RB, “Management of Streaming Body Sensor Data for Medical Information Systems. The 2003 International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences (METMBS ‘03), Las Vegas, Nevada, June 24, 2003.
27. Hofstetter, WL, Cameron, RB, Lad, T, and Holmes, EC. Surgeons Specializing In Lung Cancer Perform Higher Quality Resections. Society of Thoracic Surgeons 40th Annual Meeting, San Antonio, TX, 2004.
28. Cárdenas, AF, Pon, RK, and Cameron, R B. Management of Streaming Body Sensor Data for Medical Information Systems, 2003 International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences (METMBS ‘03), June 23, 2003, Las Vegas, Nevada.
29. Hofstetter W, Holmes EC, Cameron RB, and Lad T. Surgeons Specializing in Lung Cancer Perform Higher Quality Resections. Society of Thoracic Surgeons Annual Meeting, San Antonio, January 27, 2004.
Bibliography
Abstracts
1. Cameron RB and Rosenberg SA. In vivo synergy between interleukin-2 and interferon-a (IFN) in a murine multiple hepatic metastatic model. FASEB J 2(4):A689, 1988.
2. Cameron RB, Mule JJ, and Rosenberg SA. Evidence against a critical role for MHC upregulation in the in vivo synergistic antitumor activity of interferon-a and interleukin-2. Proc Am Assoc Cancer Res 30:390, 1989.
3. Jablons DM, Roach M, Jahan TM, and Cameron RB. Resection and intraoperative radiotherapy (IORT) followed by three-dimensional conformal radiotherapy +/- adjuvant chemotherapy for malignant mesothelioma. Proc 6th Int IORT Symposium, p. 37, 1996.
4. Rajasinghe H, Chen J, Merrick S, Keith F, Jablons DM, and Cameron RB. Postpneumonectomy pulmonary edema. Chest 110(4 suppl):80, 1996.
5. Jablons DM, Cameron RB, Xia W, Leland P, Varricchio F, and Puri R. In vitro and in vivo expression of IL-4 receptors on human malignant mesothelioma: implications for therapy. Proceedings of the American Association for Cancer Research 38:pending, 1997.
6. Jablons DM, Cameron RB, Xia W, Varricchio F, Lelan P, Kreitman R, Pastan I, Puri R. Detection of IL-4 Receptors on Human Mesotheliomas and Demonstration of Specific Cytotoxicity by a Recombinant IL-4 Pseudomonas Exotoxin Against Human Mesothelioma Cell Lines. Chest 112:115, 1997.
7. Cameron RB, Fishbein M, Crean D, Wong T, Walker J, and Holmes EC. Photodynamic therapy of the normal canine airway with a new photosensitizing agent SnET2. Ann Thoracic Surg, 1999.
8. Schiepers C, Yap CS, Meta J, Seltzer MA, Silverman DH, Gambhir SS, Cameron RB, Phelps ME, Czernin J. Staging of recurrent lung cancer: Value of FDG-PET in therapy selection and management of patients. J Nuclear Med. 41(5 Suppl.), 75P, 2000.
9. Schiepers C, Yap CS, Silverman DH, Meta J, Seltzer MA, Gambhir SS, Cameron RB, Phelps ME, Czernin J. Staging of newly diagnosed lung cancer: Impact of FDG-PET on patient management. J Nuclear Med. 41(5 Suppl.): 109P, 2000.
10. Schiepers C, Yap CS, Seltzer M, Silverman D, Cameron R, Phelps ME, Czernin J. Prognostic value of metabolic imaging in lung cancer. J Nuclear Med. 42(5 Suppl): 300P, 2001.
11. Schiepers C, Yap C, Cameron R, Phelps ME, Czernin J. Metabolic imaging in lung cancer: Prognostic significance of a negative FDG-PET scan. J Nuclear Med. 43(5 Suppl): 114P-115P, 2002
12. Yap C, Schiepers C, Cameron R, Phelps ME, Czernin J. False positive (FP) and false negative (FN) FDG-PET findings of lesions suspicious for lung cancer. J Nuclear Med 43(5 Suppl): 115P, 2002.
13. Yap C, Vranjesevic D, Cameron R, Czernin J. F18-fluoro-thymidine: a new molecular probe for PET imaging of cancer. Ann Surg Oncol: 10(1):S38, 2003.
14. Phillips M, Altorki N, Austin JH, Cameron RB, Cataneo RN, Greenberg J, Kloss R, Maxfield RA, Pass HI, Rom WN, and Tietje O. Prediction of lung cancer using volatile biomarkers in breath. J Clin Oncol 23(16S): 839S, 2005.
Papers
1. Li GC, Cameron RB, Sapareto S, and Hahn GM. Reinterpretation of the Arrhenius analysis of cell inactivation by heat. Third International Symposium: Cancer Therapy by Hyperthermia, Drugs, and Radiation. NCI Monograph 61:111-113, 1982.
2. Moore TC and Cameron RB. Spontaneous perforation of the extrahepatic biliary tract in infancy and childhood. Pediatr Surg Int 1:206-209, 1986.
3. Cameron RB, McIntosh JK, and Rosenberg SA. Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases. Cancer Res 48(20):5810-5817, 1988.
4. Eisenthal A, Cameron RB, Uppenkamp I, and Rosenberg SA. Effect of combined therapy with lymphokine-activated killer cells, interleukin-2, and specific monoclonal antibody on established B16 melanoma lung metastases. Cancer Res 48(24):7140-7145, 1988.
5. Cameron RB, Spiess PJ, and Rosenberg SA. Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin-2, and local tumor irradiation. Studies on the mechanism of action. J Exp Med 171(1):249-263, 1990.
6. Eisenthal A, Cameron RB, and Rosenberg SA. Induction of antibody-dependent cellular cytotoxicity in vivo with specific anti-B16 monoclonal antibody. J Immunol 144(11):4463-4471, 1990.
7. Bock SN, Cameron RB, Kragel P, Mule JJ, and Rosenberg SA. Biologic and antitumor effects of recombinant human macrophage colony stimulating factor in mice. Cancer Res 51(10):2649-2654, 1991.
8. Barsky SH, Cameron RB, Osann KE, Tomita DK, and Holmes AC. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathological features. Cancer 73(4):1163-1170, 1994.
9. Cameron RB, Fringer J, Taylor C, Gilden R, and Figlin RA. Practice guidelines for non-small cell lung cancer. Cancer J Sci Am 2(3A suppl):61-68, 1996.
10. Cameron RB, Smith NG, Taylor C, Gilden R, and Figlin RA. Practice guidelines for small cell lung cancer. Cancer J Sci Am 2(3A suppl):69-75, 1996.
11. Jablons DM, Roach M, Jahan T, and Cameron RB. Resection and intraoperative radiotherapy (IORT) followed by three-dimensional conformal radiotherapy +/- adjuvant chemotherapy for malignant mesothelioma. Frontiers of Radiat Ther Oncol 31:140-145, 1997.
12. Key SP, Cameron RB, and Jablons DM. The Heimlich Device in Thoracic Surgery. Surgical Tech Int’l VI 91-95, 1997.
13. Xia W, Jablons DM, and Cameron RB. Presentation of tumor antigens by peripheral blood derived dendritic cells in lung cancer patients. Surg Forum 49:432, 1998.
14. Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, Li JD, Basbaum C. Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38. FEBS Lett. 441(1):88-92, 1998.
15. Beseth B, Bedford R, Isacoff W, Holmes EC, and Cameron RB. The use of endoscopic ultrasound in the assessment of response following induction therapy in esophageal carcinoma. Am J Surg 66(9):827-31, 2000.
16. Lee TT, Everett DL, Shu HK, Jahan TM, Roach M 3rd, Speight JL, Cameron RB, Phillips TL, Chan A, Jablons DM. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 124(6):1183-9, 2002.
17. Cárdenas, AF, Pon, RK, and Cameron, RB. Management of Streaming Body Sensor Data for Medical Information Systems, 2003 International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences (METMBS ‘03), June 23-26, 2003, Las Vegas, Nevada.
18. Beseth B, Cameron RB, Leland P, You L, Varricchio F, Kreitman R, Maki RA, Pastan I, Jablons DM, Husain SR, Puri R. Cytotoxin directed to Interleukin-4 receptors for therapy of human malignant pleural mesothelioma xenographs. Ann Thorac Surg, Ann. 78:436-443, 2004.
19. Cárdenas, AF, Pon, RK, Cameron, RB, and Coyle, MA, “The Mobile Patient and Mobile Physician Data Access and Transmission,” The 2005 International Conference on Mathematics and Engineering Techniques in Medicine and Biological Sciences (METMBS ‘05), June 20-23, 2005, Las Vegas, Nevada
20. Dohadwala1 M, SC Yang, Luo J, Sharma1 S, Batra RK, Huang1 M, Lin Y, Goodglick L, Krysan K, Fishbein MC, Hong L, Cameron RB, Gemmill RM, Drabkin HA, Dubinett SM. Cyclooxygenase-2-dependent regulation of E-cadherin expression: PGE2 induces E-cadherin transcriptional repressors ZEB1 and Snail in NSCLC (JCI submitted)
21. Beseth B and Cameron RB. Acute Closure of Parenchymal Air Leaks and Buttressing of Bronchial Closures in an Ex-vivo Swine model. Chest (in preparation).
22. Cameron RB, Fishbein M, Crean D, Wong T, Walker J, and Holmes EC. Photodynamic therapy using a new photosensitizing agent SnET2 in canine airways (in preparation).
23. Cameron RB. Gastropulmonary fistula presenting as a lung abscess: a rare complication of abdominal surgery. (in preparation).
24. Cameron RB. Dermal Metastasis: A novel complication of thoracic epidural catheters. (in preparation).
Other peer-reviewed publications
1. Cameron RB. Lung cancer: specifications for acceptable care. Preferred Health Systems, LLC, Bethesda, Maryland, 1996.
Book Chapters
1. Cameron RB. Introduction to the cancer patient. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
2. Cameron RB. Principles of surgical oncology. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
3. Cameron RB. Principles of Immunotherapy. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
4. Rose L and Cameron RB. Metabolic problems and emergencies. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
5. Rose L and Cameron RB. Infectious problems and emergencies. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
6. Rose L and Cameron RB. Dermatologic problems and emergencies. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
7. Cameron RB and Wong J. Melanoma. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
8. Cameron RB. Malignancies of the lung. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
9. Cameron RB. Malignancies of the pleura. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
10. Cameron RB. Malignancies of the mediastinum. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
11. Cameron RB. Malignancies of the esophagus. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
12. Cameron RB. Malignancies of the stomach. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
13. Cameron RB. Malignancies of the small bowel. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
14. Cameron RB. Malignancies of the exocrine pancreas. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
15. Wade T and Cameron RB. Malignancies of the liver and intrahepatic biliary tract. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
16. Wade T and Cameron RB. Malignancies of the gallbladder and extrahepatic biliary tract. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
17. Cameron RB. Malignancies of the colon. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
18. Cameron RB. Malignancies of the rectum. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
19. Cameron RB. Malignancies of the anus. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
20. Cameron RB. Malignancies of the adrenal medulla. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
21. Cameron RB. Malignancies of unknown primary site. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
22. McIntosh J and Cameron RB. Ewing’s sarcoma. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
23. McIntosh J and Cameron RB. Rhabdomyosarcoma. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
24. McIntosh J and Cameron RB. Neuroblastoma. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
25. McIntosh J and Cameron RB. Retinoblastoma. in Practical Oncology, Robert B. Cameron, editor, Appleton & Lange, Norwalk, CT, 1994.
26. Cameron RB and Gonella JS. Classification Systems (TNM and Disease). in Clinician’s Pocket Reference, Gomella LG, editor, Appleton & Lange, Norwalk, CT, 7th edition, 1993.
27. Cameron RB and Ginsberg RJ. Surgery and neoadjuvant chemotherapy for non-small cell lung cancer. in Lung Cancer, Carney D, editor, Edward Arnold, Sevenoaks, Kent, England, 1995.
28. Hodder RV, Cameron RB, and Todd TRJ. Lung infections: Bacterial infections. in Thoracic Surgery, Pearson FG, Deslauriers J, Ginsberg RJ, et. al., editors. Churchill Livingstone, New York, 1995.
29. Cameron RB. Contributor. Surgery On Call, Gomella LG and Lefor AT, editors. Appleton & Lange, Norwalk, CT, 2nd edition, 1996.
30. Cameron RB and Jablons DM. Chest wall, pleura, mediastinum, and lung. in Current Surgical Diagnosis and Treatment. Way L, editor. Appleton & Lange, Norwalk, CT, 10th edition, 1996.
31. Cameron RB and Gonella JS. Classification Systems (TNM and Disease). in Clinician’s Pocket Reference, Gomella LG, editor, Appleton & Lange, Norwalk, CT, 8th edition, 1996.
32. Cameron RB. Bedside procedures. in Clinician’s Pocket Reference, Gomella LG, editor. Appleton & Lange, Norwalk, CT, 8th edition, 1996.
33. Robles R, Cameron RB, Roach M, and Cornett P. Lung Cancer. in Current Cancer Diagnosis and Treatment. Henderson IC and Northfelt D, editors. Appleton & Lange, Norwalk, CT, 1997 (in press).
34. Prager D, Cameron RB, Ford J, and Figlin RA. Bronchogenic Carcinoma. In: Textbook of Respiratory Medicine, Murray JF, Nadel JA, Mason RJ, et. al. eds., 3rd ed., Saunders, Philadelphia, 1999.
35. Figlin RA, Cameron RB, and Turrisi AT. Non-small cell lung cancer. In: Cancer Treatment, Haskell CM, ed. 5th ed., Saunders, Philadelphia, 1999.
36. Cameron RB, Loehrer PJ, and Thomas CR. Neoplasms of the Mediastinum. In: Cancer: Principles and Practice of Oncology, DeVita VT, Hellman S, and Rosenberg SA, eds. 6th ed. Lippincott-Raven, Philadelphia, 2000.
37. Beseth, BD, Cameron RB, Mule JJ. Human Gene Therapy. In: Surgery: Scientific Principles and Practice., Greenfield LJ, ed. 3rd ed. Lippicott Williams & Wilkins, Philadelphia, 2001.
38. Cameron RB, Loehrer PJ, and Thomas CR. Neoplasms of the Mediastinum. In: Cancer: Principles and Practice of Oncology, DeVita VT, Hellman S, and Rosenberg SA, eds. 7th ed. Lippincott-Raven, Philadelphia, 2005.
39. Cameron RB and Andaz S. Management of Pleural Effusions in Mesothelioma. In: Mesothelioma Pass H et. al., eds. Springer-Verlag, New York, 2005.
Books
1. Cameron RB and Schwarz SL, editors. Laboratory Protocols for the Immunotherapy of Cancer. Surgery Branch, National Cancer Institute, Bethesda, MD, 1989.
2. Cameron RB, editor. Practical Oncology. Appleton & Lange, Norwalk, CT, 1994.
Reviews
1. Cameron RB. Book review of Atlas of video-assisted thoracic surgery by WT Brown. Surg Endo 9: 1995.
2. Cameron RB. Book review of General Thoracic Surgery by TW Shields, et. al. World J Surg, 24(12): 1599C-1600, 2000.
3. Cameron, RB Invited commentary on Expansion of chondrocytes in a three-dimensional matrix for tracheal tissue engineering Ann Thorac Surg, 78:448-449, 2004.